Prostate cancer is a prevalent malignancy that affects the prostate gland, a small walnut-shaped gland in men that produces seminal fluid. It is one of the most common cancers among men worldwide. Prostate cancer typically develops slowly and may not cause symptoms in its early stages. However, as the cancer progresses, symptoms may include urinary problems such as frequent urination, difficulty starting or stopping urination, weak urine flow, blood in the urine, erectile dysfunction, pain in the hips, back, or pelvis, and unexplained weight loss. Risk factors for prostate cancer include age, family history, ethnicity, and certain genetic mutations. Diagnosis involves a combination of digital rectal examination, prostate-specific antigen (PSA) blood test, imaging studies such as MRI or ultrasound, and biopsy. Treatment options vary depending on the stage and aggressiveness of the cancer and may include active surveillance, surgery, radiation therapy, hormone therapy, chemotherapy, immunotherapy, or targeted therapy. Early detection and treatment play a crucial role in improving outcomes and quality of life for individuals diagnosed with prostate cancer. Regular screening and consultation with a healthcare professional are essential for men, especially those at higher risk, to detect and manage prostate cancer effectively.